miR-1258: A novel microRNA that controls TMPRSS4 expression is associated with malignant progression of papillary thyroid carcinoma.
Conclusion Taken together, our research work raised the possibility that miR-1258 was an anti-oncogene, which exerts its anti-cancer function via targets TMPRSS4. Hence, it may be possible to treat PTC via targeting MIR-1258 / TMPRSS4 axis in the future.
PMID: 32154571 [PubMed - as supplied by publisher]
Source: Endokrynologia Polska - Category: Endocrinology Authors: Wang LJ, Cai HQ Tags: Endokrynol Pol Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Endocrinology | Genetics | Thyroid | Thyroid Cancer